GE HealthCare Technologies Inc. vs Eli Lilly & Co.
GEHC vs LLY — side-by-side comparison from reported financials. GEHC leads 1, LLY leads 9 of 10 comparable metrics.
GE HealthCare Technologies Inc.
GEHC · Healthcare
$65.74+2.37%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | GEHC | LLY |
|---|---|---|
| Price | $65.74 | $1 177.20 |
| Market cap | $29.7B | $1.05T |
| Revenue (TTM) | $21.3B | $79.7B |
| Revenue growth | +4.0% | +31.7% |
| Net margin | 9.3% | 33.5% |
| Free cash flow | $1.58B | $18.2B |
| Net cash (debt) | — | ($35.2B) |
| 1-year price return | -11.4% | +37.6% |
| P/E | 15.0 | 41.6 |
| P/E vs own history (cheap-side %) | 87% | 88% |
| Dividend yield | 0.22% | 0.52% |
| Return on equity | 19% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 54,000 | 50,000 |
Full résumé-style profiles: GEHC CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.